Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Continuing Increase in Infectious Syphilis— United States

Continuing Increase in Infectious Syphilis— United States outbreaks of influenza use in institutions 972.) A(H3N2) at (Continuedfrom among particularly caring is not residents of for is available (heterovariant) protection pre¬ high-risk nursing homes, high-risk persons, known. vari¬ that the the Office of Public suggest cisely Although antigenic A/Leningrad/360/86 through Inquiries, differ in of the vaccine Centers for Clif¬ ants some on the hem- current Disease 1600 component Control, epitopes may ton also share other not agglutinin, they provide optimal protection against Road, NE, Atlanta, Georgia30333. Be¬ strains. These common hemagglutinin epitopes. presently circulating cause viruses have circu¬ the need for health¬ References A(H3N2) type findings emphasize lated since of the care be aware of the recom¬ most to 1. Centers for Disease Control. influenza 1968, population providers Update: States. MMWR has been circulat¬ mendations for use of the antiviral activity\p=m-\United 1988;37:49-50. primed by previously drug 2. Barker JP. Effectiveness of inac- WH, Mullooly strains and more re¬ amantadine for outbreaks ing is, therefore, controlling tivated influenza non-institutional- vaccine among heterovariant immuniza¬ and for or of un¬ to treatment sponsive prophylaxis ized Kendal Patriarca elderly In: AP, PA, persons. tion. In the Because eds. for the control of influenza: amanta¬ Options proceed- addition, antigenic changes protected patients.7 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Continuing Increase in Infectious Syphilis— United States

JAMA , Volume 259 (7) – Feb 19, 1988

Loading next page...
 
/lp/american-medical-association/continuing-increase-in-infectious-syphilis-united-states-q7BOHw6QvI

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1988 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1988.03720070011008
Publisher site
See Article on Publisher Site

Abstract

outbreaks of influenza use in institutions 972.) A(H3N2) at (Continuedfrom among particularly caring is not residents of for is available (heterovariant) protection pre¬ high-risk nursing homes, high-risk persons, known. vari¬ that the the Office of Public suggest cisely Although antigenic A/Leningrad/360/86 through Inquiries, differ in of the vaccine Centers for Clif¬ ants some on the hem- current Disease 1600 component Control, epitopes may ton also share other not agglutinin, they provide optimal protection against Road, NE, Atlanta, Georgia30333. Be¬ strains. These common hemagglutinin epitopes. presently circulating cause viruses have circu¬ the need for health¬ References A(H3N2) type findings emphasize lated since of the care be aware of the recom¬ most to 1. Centers for Disease Control. influenza 1968, population providers Update: States. MMWR has been circulat¬ mendations for use of the antiviral activity\p=m-\United 1988;37:49-50. primed by previously drug 2. Barker JP. Effectiveness of inac- WH, Mullooly strains and more re¬ amantadine for outbreaks ing is, therefore, controlling tivated influenza non-institutional- vaccine among heterovariant immuniza¬ and for or of un¬ to treatment sponsive prophylaxis ized Kendal Patriarca elderly In: AP, PA, persons. tion. In the Because eds. for the control of influenza: amanta¬ Options proceed- addition, antigenic changes protected patients.7

Journal

JAMAAmerican Medical Association

Published: Feb 19, 1988

There are no references for this article.